Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
PUT
Cirrus Logic
CRUS
$6.07B
| $5.28M | ﹤0.01% |
101,800
+45,000
| +79% | +$2.43M |
|
|
QEP
2277
DELISTED
QEP RESOURCES, INC.
QEP
| $5.28M | ﹤0.01% |
551,554
-144,678
| -21% | -$1.31M |
|
|
SGMO
2278
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $5.28M | ﹤0.01% |
321,648
-42,747
| -12% | -$636K |
|
2279
AMERISAFE
AMSF
$513M
| $5.27M | ﹤0.01% |
85,594
-7,480
| -8% | -$470K |
|
2280
Assured Guaranty
AGO
$3.38B
| $5.27M | ﹤0.01% |
155,597
+94,448
| +154% | +$3.42M |
|
2281
PUT
Mattel
MAT
$4.29B
| $5.25M | ﹤0.01% |
341,600
-25,100
| -7% | -$398K |
|
2282
PUT
Sociedad Química y Minera de Chile
SQM
$21.2B
| $5.25M | ﹤0.01% |
88,400
+4,000
| +5% | +$229K |
|
2283
Tapestry
TPR
$25.7B
| $5.25M | ﹤0.01% |
118,620
-250,182
| -68% | -$10.3M |
|
2284
Philip Morris
PM
$297B
| $5.24M | ﹤0.01% |
49,628
-483,452
| -91% | -$51.5M |
|
2285
PUT
SolarEdge
SEDG
$1.99B
| $5.24M | ﹤0.01% |
139,600
+68,100
| +95% | +$2.34M |
|
2286
ING
ING
$102B
| $5.24M | ﹤0.01% |
283,646
-241,156
| -46% | -$4.42M |
|
2287
PUT
H&R Block
HRB
$6.83B
| $5.23M | ﹤0.01% |
199,600
+22,700
| +13% | +$589K |
|
|
COR
2288
DELISTED
Coresite Realty Corporation
COR
| $5.23M | ﹤0.01% |
45,936
-10,633
| -19% | -$1.21M |
|
2289
Agios Pharmaceuticals
AGIO
$2B
| $5.23M | ﹤0.01% |
+91,470
| New | +$5.76M |
|
2290
Essent Group
ESNT
$6.25B
| $5.23M | ﹤0.01% |
120,404
+113,471
| +1,637% | +$4.94M |
|
2291
Vermilion Energy
VET
$1.73B
| $5.23M | ﹤0.01% |
143,450
+127,346
| +791% | +$4.44M |
|
2292
Adtran
ADTN
$684M
| $5.22M | ﹤0.01% |
269,729
+60,779
| +29% | +$1.35M |
|
2293
CALL
Pultegroup
PHM
$24.8B
| $5.21M | ﹤0.01% |
156,800
-76,500
| -33% | -$2.38M |
|
2294
CALL
Dover
DOV
$27.9B
| $5.21M | ﹤0.01% |
63,881
+26,865
| +73% | +$2.08M |
|
|
ICPT
2295
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $5.21M | ﹤0.01% |
89,100
-3,200
| -3% | -$202K |
|
2296
CALL
Estee Lauder
EL
$31.2B
| $5.2M | ﹤0.01% |
40,900
-53,400
| -57% | -$6.42M |
|
|
CLVS
2297
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $5.2M | ﹤0.01% |
76,400
+3,200
| +4% | +$224K |
|
|
ABMD
2298
PUT
DELISTED
Abiomed Inc
ABMD
| $5.19M | ﹤0.01% |
27,700
+18,500
| +201% | +$3.45M |
|
2299
PUT
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $5.19M | ﹤0.01% |
44,700
-3,600
| -7% | -$416K |
|
2300
CALL
Hershey
HSY
$37B
| $5.19M | ﹤0.01% |
45,700
+23,400
| +105% | +$2.57M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.